GrahamB wrote:
I am glad the longs had a little break after the negative NICE report.
Not nice to see people suffer for sure, as the downtrend was pretty massive early on
I wonder if those who speculateD that someone complained, and had NICE have tye repirt reviewed
I am sure it rattled some when a external report objectively points out issues with the technology and the stock drops like a rock
Unfortunately,
Like the Greeks who defeated the Roman’s -suspect
It’s a pyrrhic victory
The report was exactly as I had suspected and had posted. The experts, on balance, felt that the technology is not supported enough by the evidence, for recommending across the UK
NICE may hold the report temporarily,but IMO expect it to come back as it’s not like the data is going to change.
Having the external validation was something that everyone was looking for, but when it doesn’t come through to support VPT the narrative changes, and now we’re not supposed to care at all about this report.
What was supposed to be a report that meant the UK would have to buy thousands of units, and it would become standard of care, has fallen flat.
No matter how it’s painted, people have posted about this for months, and indicated that the price was going to soar after this report.
Too bad, objective evaluations,by distinguished cardiologists representing a national body have , the same concerns, that many of us have after reviewing the data , and it’s going to need more studies, larger studies, before this gets traction, and significant sales.
In truth, I don’t feel happy, that the company is not being successful, more that my evaluation and objective analysis are validated. It tells me that the process I use, works.
Hope they can get a few sales to keep this rolling so that they can see if this technology can be adopted.
So we can wait now for the verified financials to see if that’s the case. Very happy to sit on the sidelines and wait until the business proves itself. Good luck to the Speculators